These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33155836)

  • 1. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
    Yang L; Wei C; Li Y; He X; He M
    Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma.
    El-Naidany SS; Zid E; Reda FM; Nada A; Fouda EAM
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2687-2693. PubMed ID: 36037122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 9. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.
    Huang HQ; Chen G; Xiong DD; Lai ZF; Liu LM; Fang YY; Shen JH; Gan XY; Liao LF; Dang YW
    Bioengineered; 2021 Dec; 12(1):1627-1641. PubMed ID: 33949293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
    Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Ming XL; Feng YL; He DD; Luo CL; Rong JL; Zhang WW; Ye P; Chai HY; Liang CZ; Tu JC
    Epigenomics; 2019 Aug; 11(10):1209-1231. PubMed ID: 31339046
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.
    Tsang FH; Au V; Lu WJ; Shek FH; Liu AM; Luk JM; Fan ST; Poon RT; Lee NP
    Dig Dis Sci; 2014 Oct; 59(10):2477-87. PubMed ID: 24811246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y; Yan D; Wang L; Zhang J; He Q
    J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
    Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
    J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.